Edition:
United States

Ankur Banerjee

Walmart opts to leave CVS partnerships over pricing dispute

Jan 15 2019

CVS Health Corp said on Tuesday Walmart Inc is leaving its network for commercial and Medicaid prescription drug plans after the two companies failed to agree on pricing.

Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy

Jan 07 2019

Eli Lilly said on Monday it will buy Loxo Oncology Inc for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in the drugmaker's 143-year history. The price represents a 68 percent premium to Loxo's Friday share price close, which some Wall Street analysts said was high for a company with only one drug on the market that it shares with a partner. | Video

Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal

Jan 04 2019

Bristol-Myers Squibb Co said on Thursday it would buy Celgene Corp for about $74 billion, combining two of the world's largest cancer drug businesses in the biggest pharmaceutical deal ever. | Video

Allergan stops sale of textured breast implants in Europe, shares sink

Dec 19 2018

NEW YORK Drugmaker Allergan Plc said on Wednesday it would take its textured breast implants off the market in Europe, a day after a French regulatory body ordered a recall of the implants, which have been linked to a rare form of cancer.

Allergan stops sale of textured breast implants in Europe, shares sink

Dec 19 2018

NEW YORK Drugmaker Allergan Plc said on Wednesday it would take its textured breast implants off the market in Europe, a day after a French regulatory body ordered a recall of the implants, which have been linked to a rare form of cancer.

Cannabis abstinence tied to memory improvement in adolescents, young adults

Nov 30 2018

(Reuters Health) - - Not using cannabis for a month could improve learning ability for adolescents and young adults who used the drug at least weekly, a U.S. study suggests.

Treating gum disease may help control type 2 diabetes

Nov 26 2018

(Reuters Health) - Treating chronic gum inflammation might help people with diabetes control their disease, a recent study suggests.

Sit-stand desks cut daily sitting time, may help engage workers

Nov 06 2018

(Reuters Health) - Sit-stand desks reduce daily sitting time and may improve job performance and work engagement, a British study suggests.

Amnesty policies may curb alcohol emergencies at universities

Oct 25 2018

(Reuters Health) - Amnesty policies may encourage college students to call for help with alcohol-related issues before they or their intoxicated peers become seriously ill, a U.S. study suggests.

Eisai, Biogen Alzheimer's data fails to convince skeptics

Oct 25 2018

Eisai Co Ltd and partner Biogen Inc said on Thursday that the highest dose of their experimental Alzheimer's disease drug showed effectiveness in a new analysis, but investors remained skeptical about the reliability of the data and Biogen shares fell about 2 percent.

World News